
	Dr. de Silva has nearly a dozen years of experience in biopharmaceutical venture capital and healthcare management consulting. Most recently he served as Principal at the private equity firm Warburg Pincus LLC, where he was responsible for identifying and sourcing late-stage biopharmaceutical investment opportunities. Previously he worked at the Sprout Group, a venture capital firm, and was a healthcare consultant at McKinsey &amp; Company. Over the last several years, he has evaluated hundreds of biotech company investment opportunities, negotiated and structured major equity positions for several companies and served on the Board of Directors for three public companies.
	
	Dr. de Silva holds a B.A. in Biology from Harvard University, an M.D. from The University of Pennsylvania School of Medicine and an M.B.A. from The Wharton School.
